Gastric Cancer Archives - Cancer Therapy Advisor

Close-up of pills scattered around the white bottle on a green background

Regorafenib Plus Chemo and Nivolumab Shows Activity in Esophagogastric Cancer

By

Jen Smith

September 7, 2023

First-line regorafenib plus nivolumab and chemotherapy has shown activity in patients with HER2-negative metastatic esophagogastric cancer in a phase 2 trial.

Gastrointestinal Cancers

Vitamin D3 Improves RFS in p53-Immunoreactive Gastrointestinal Tract Cancers

By

Andrea S. Blevins Primeau, PhD, MBA

August 30, 2023

Vitamin D3 supplementation may improve relapse-free survival in certain patients with gastrointestinal tract cancers, data suggest.

General Oncology

Delaying Chemotherapy in Asymptomatic Cancer Patients Does Not Impact Survival

By

Leah Lawrence

August 23, 2023

A meta-analysis suggests that delaying chemotherapy in patients with asymptomatic, advanced cancer does not worsen overall survival.

ASCO Breakthrough 2023

SPOT-MAS Assay Can Detect Presence, Location of Multiple Cancers

By

Julie Ehlers

August 9, 2023

A blood-based test called SPOT-MAS can determine the presence and location of multiple cancers, a new study suggests.

Gastrointestinal Cancers

Zolbetuximab Plus mFOLFOX6 Shows Activity in CLDN18.2+ Gastric/GEJ Cancer

By

Leah Lawrence

July 31, 2023

Zolbetuximab plus mFOLFOX6 has demonstrated efficacy in a phase 2 trial of patients with CLDN18.2+ advanced gastric/GEJ cancer.

Gastrointestinal Cancers

Neoadjuvant Therapies Confer Survival Benefit in Esophageal, GEJ Cancer

By

Leah Lawrence

July 21, 2023

Neoadjuvant chemotherapy or chemoradiotherapy improves outcomes in patients with esophageal or gastroesophageal junction cancer, a meta-analysis suggests.